Cargando…

Secondary stroke prevention: challenges and solutions

Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Esenwa, Charles, Gutierrez, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536764/
https://www.ncbi.nlm.nih.gov/pubmed/26300647
http://dx.doi.org/10.2147/VHRM.S63791
_version_ 1782385794222129152
author Esenwa, Charles
Gutierrez, Jose
author_facet Esenwa, Charles
Gutierrez, Jose
author_sort Esenwa, Charles
collection PubMed
description Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk factors such as hypertension, diabetes, dyslipidemia, and smoking cessation. Changes in lifestyle like a healthy diet and aerobic exercise are also recommended strategies. In the case of cardioembolism due to atrial fibrillation, mechanical valves, or cardiac thrombus, anticoagulation is the mainstay of therapy. The role of anticoagulation is less evident in the case of bioprosthetic valves, patent foramen ovale, and dilated cardiomyopathy with low ejection fraction. Strokes due to larger artery atherosclerosis account for approximately a third of all strokes. In the case of symptomatic extracranial carotid stenosis, surgical intervention as close as possible in time to the index event seems highly beneficial. In the case of intracranial large artery atherosclerosis, the best medical therapy consists of antiplatelets, high-dose statins, aggressive controls of vascular risk factors, and lifestyle modifications, with no role for intracranial arterial stenting or angioplasty. For patients with small artery occlusion (ie, lacunar stroke), the therapy is similar to that used in patients with intracranial large artery atherosclerosis. Despite the constant new evidence on how to best treat patients who have suffered a stroke, the risk of stroke recurrence remains unacceptably high, thus evidencing the need for novel therapies.
format Online
Article
Text
id pubmed-4536764
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45367642015-08-21 Secondary stroke prevention: challenges and solutions Esenwa, Charles Gutierrez, Jose Vasc Health Risk Manag Review Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk factors such as hypertension, diabetes, dyslipidemia, and smoking cessation. Changes in lifestyle like a healthy diet and aerobic exercise are also recommended strategies. In the case of cardioembolism due to atrial fibrillation, mechanical valves, or cardiac thrombus, anticoagulation is the mainstay of therapy. The role of anticoagulation is less evident in the case of bioprosthetic valves, patent foramen ovale, and dilated cardiomyopathy with low ejection fraction. Strokes due to larger artery atherosclerosis account for approximately a third of all strokes. In the case of symptomatic extracranial carotid stenosis, surgical intervention as close as possible in time to the index event seems highly beneficial. In the case of intracranial large artery atherosclerosis, the best medical therapy consists of antiplatelets, high-dose statins, aggressive controls of vascular risk factors, and lifestyle modifications, with no role for intracranial arterial stenting or angioplasty. For patients with small artery occlusion (ie, lacunar stroke), the therapy is similar to that used in patients with intracranial large artery atherosclerosis. Despite the constant new evidence on how to best treat patients who have suffered a stroke, the risk of stroke recurrence remains unacceptably high, thus evidencing the need for novel therapies. Dove Medical Press 2015-08-07 /pmc/articles/PMC4536764/ /pubmed/26300647 http://dx.doi.org/10.2147/VHRM.S63791 Text en © 2015 Esenwa and Gutierrez. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Esenwa, Charles
Gutierrez, Jose
Secondary stroke prevention: challenges and solutions
title Secondary stroke prevention: challenges and solutions
title_full Secondary stroke prevention: challenges and solutions
title_fullStr Secondary stroke prevention: challenges and solutions
title_full_unstemmed Secondary stroke prevention: challenges and solutions
title_short Secondary stroke prevention: challenges and solutions
title_sort secondary stroke prevention: challenges and solutions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536764/
https://www.ncbi.nlm.nih.gov/pubmed/26300647
http://dx.doi.org/10.2147/VHRM.S63791
work_keys_str_mv AT esenwacharles secondarystrokepreventionchallengesandsolutions
AT gutierrezjose secondarystrokepreventionchallengesandsolutions